LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION April 1, 2025 TO: Honorable Charles Perry, Chair, Senate Committee on Water, Agriculture and Rural Affairs FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB261 by Perry (relating to the prohibited manufacture, processing, possession, distribution, offering for sale, and sale of cell-cultured protein.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources. Local Government ImpactNo significant fiscal implication to units of local government is anticipated. Source Agencies: b > td > 537 State Health Services, Department of LBB Staff: b > td > JMc, FV, ER, APA
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
April 1, 2025
TO: Honorable Charles Perry, Chair, Senate Committee on Water, Agriculture and Rural Affairs FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB261 by Perry (relating to the prohibited manufacture, processing, possession, distribution, offering for sale, and sale of cell-cultured protein.), Committee Report 1st House, Substituted
TO: Honorable Charles Perry, Chair, Senate Committee on Water, Agriculture and Rural Affairs
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB261 by Perry (relating to the prohibited manufacture, processing, possession, distribution, offering for sale, and sale of cell-cultured protein.), Committee Report 1st House, Substituted
Honorable Charles Perry, Chair, Senate Committee on Water, Agriculture and Rural Affairs
Honorable Charles Perry, Chair, Senate Committee on Water, Agriculture and Rural Affairs
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
SB261 by Perry (relating to the prohibited manufacture, processing, possession, distribution, offering for sale, and sale of cell-cultured protein.), Committee Report 1st House, Substituted
SB261 by Perry (relating to the prohibited manufacture, processing, possession, distribution, offering for sale, and sale of cell-cultured protein.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 537 State Health Services, Department of
537 State Health Services, Department of
LBB Staff: b > td > JMc, FV, ER, APA
JMc, FV, ER, APA